skip to primary navigationskip to content

Recent publication in collaboration with Dr Peter Scott’s group in The University of Michigan Medical School.

last modified May 20, 2015 03:45 PM
Synthesis and Initial in Vivo Studies with [11C]SB-216763: The First Radiolabeled Brain Penetrative Inhibitor of GSK-3

WBIC PET Chemistry team has a recent publication in collaboration with Dr Peter Scott’s group in The University of Michigan Medical School.

We have developed a novel one-pot two-step method for the radiosynthesis of [11C]SB-216763 and demonstrated that it is the first radiotracer for GSK-3 able to cross the Blood-brain Barrier and enter the central nervous system in both rodents and nonhuman primates. The arylindolemaleimide skeleton represents our lead scaffold for developing a radiotracer for quantification of GSK-3 in vivo using brain PET and ultimately translating it into clinical use.

 

The article is published in recent journal of ACS Medicinal Chemistry Letters

 

http://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.5b00044

Upcoming events

WBIC MRI and Radiation Safety Course

Sep 11, 2017

LMI conference room on the West Forvie site.

WBIC MRI and Radiation Safety Course

Nov 20, 2017

LMI conference room on the West Forvie site.

Previous events

Upcoming events